首页> 美国卫生研究院文献>World Journal of Gastroenterology >Overexpressed miRNA-155 dysregulates intestinal epithelial apical junctional complex in severe acute pancreatitis
【2h】

Overexpressed miRNA-155 dysregulates intestinal epithelial apical junctional complex in severe acute pancreatitis

机译:在严重急性胰腺炎中miRNA-155的过表达会异常调节肠上皮顶部连接复合物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate whether miRNA-155 (miR-155) dysregulates apical junctional complex (AJC) protein expression in experimental severe acute pancreatitis (SAP).METHODS: Twenty-four male BALB/c mice were randomly assigned to two groups: the SAP group (n = 12) receiving sequential intraperitoneal injection of 50 µg/kg caerulein and 10 mg/kg lipopolysaccharide over 6 h, and the control group (n = 12) receiving intraperitoneal injection of normal saline. Animals were sacrificed 3 h following the last injection for collection of blood samples and pancreas and distal ileal segment specimens. Routine pancreas and intestine histology was used to assess SAP pathology and intestinal epithelial barrier damage. Levels of serum amylase, diamine oxidase (DAO), and tumor necrosis factor (TNF)-α were determined using commercial kits. Total RNA samples were isolated from intestinal epithelial specimens and reversely transcribed into cDNA. miR-155 and RhoA mRNA expression profiles were determined using quantitative real-time polymerase chain reaction. Target genes for miR-155 were predicted using the miRTarBase database, RNA22 and PicTar computational methods. Western blotting was performed to quantitate the protein expression levels of the target gene RhoA, as well as zonula occludens (ZO)-1 and E-cadherin, two AJC component proteins.RESULTS: Intraperitoneal injection of caerulein and lipopolysaccharide successfully induced experimental acute pancreatic damage (SAP vs control, 10.0 ± 2.0 vs 3.2 ± 1.2, P < 0.01) and intestinal epithelial barrier damage (3.2 ± 0.7 vs 1.4 ± 0.7, P < 0.01). Levels of serum amylase (21.6 ± 5.1 U/mL vs 14.3 ± 4.2 U/mL, P < 0.01), DAO (21.4 ± 4.1 mg/mL vs 2.6 ± 0.8 mg/mL, P < 0.01), and TNF-α (61.0 ± 15.1 ng/mL vs 42.9 ± 13.9 ng/mL, P < 0.01) increased significantly in SAP mice compared to those in control mice. miR-155 was significantly overexpressed in SAP intestinal epithelia (1.94 ± 0.50 fold vs 1.03 ± 0.23 fold, P < 0.01), and RhoA gene containing three miR-155-specific binding sites in the three prime untranslated regions was one of the target genes for miR-155. RhoA (22.7 ± 5.8 folds vs 59.6 ± 11.6 folds, P < 0.01), ZO-1 (46 ± 18 folds vs 68 ± 19 folds, P < 0.01), and E-cadherin proteins (48 ± 15 folds vs 77 ± 18 folds, P < 0.01) were underexpressed in SAP intestinal epithelia although RhoA mRNA expression was not significantly changed in SAP (0.97 ± 0.18 folds vs 1.01 ± 0.17 folds, P > 0.05).CONCLUSION: TNF-α-regulated miR-155 overexpression inhibits AJC component protein syntheses of ZO-1, and E-cadherin by downregulating post-transcriptional RhoA expression, and disrupts intestinal epithelial barrier in experimental SAP.
机译:目的:研究miRNA-155(miR-155)在实验性重症急性胰腺炎(SAP)中是否异常调节顶端连接复合体(AJC)的蛋白表达。方法:24只雄性BALB / c小鼠随机分为两组:SAP组(n = 12)在6 h内连续腹膜内注射50 µg / kg芥蓝素和10 mg / kg脂多糖,对照组(n = 12)腹膜内注射生理盐水。最后一次注射后3小时处死动物以收集血液样品和胰腺以及回肠末段样品。常规胰腺和肠道组织学用于评估SAP病理学和肠道上皮屏障损害。使用商业试剂盒测定血清淀粉酶,二胺氧化酶(DAO)和肿瘤坏死因子(TNF)-α的水平。从肠上皮标本中分离出总RNA样品,然后反转录为cDNA。使用定量实时聚合酶链反应确定miR-155和RhoA mRNA表达谱。使用miRTarBase数据库,RNA22和PicTar计算方法预测了miR-155的靶基因。 Western blotting定量了靶基因RhoA以及两个AJC成分蛋白zonula occludens(ZO)-1和E-cadherin的蛋白表达水平。 (SAP vs对照,10.0±2.0 vs 3.2±1.2,P <0.01)和肠上皮屏障损伤(3.2±0.7 vs 1.4±0.7,P <0.01)。血清淀粉酶(21.6±5.1 U / mL vs 14.3±4.2 U / mL,P <0.01),DAO(21.4±4.1 mg / mL vs 2.6±0.8 mg / mL,P <0.01)和TNF-α(与对照组相比,SAP小鼠的61.0±15.1 ng / mL与42.9±13.9 ng / mL相比,P <0.01)显着增加。 miR-155在SAP肠上皮中显着过表达(1.94±0.50倍对1.03±0.23倍,P <0.01),并且在三个主要非翻译区域中包含三个miR-155特异性结合位点的RhoA基因是目标基因之一适用于miR-155。 RhoA(22.7±5.8倍vs 59.6±11.6倍, P <0.01),ZO-1(46±18倍 vs 68±19倍, P < / em> <0.01)和E-cadherin蛋白(48±15倍 vs 77±18倍, P <0.01)在SAP肠上皮细胞中表达不足,尽管RhoA mRNA SAP中的表达没有显着变化( vs 1.01±0.17倍,0.97±0.18倍, P

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号